These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24226091)

  • 1. Simultaneous detection of antibodies against Apx toxins ApxI, ApxII, ApxIII, and ApxIV in pigs with known and unknown Actinobacillus pleuropneumoniae exposure using a multiplexing liquid array platform.
    Giménez-Lirola LG; Jiang YH; Sun D; Hoang H; Yoon KJ; Halbur PG; Opriessnig T
    Clin Vaccine Immunol; 2014 Jan; 21(1):85-95. PubMed ID: 24226091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA.
    Dreyfus A; Schaller A; Nivollet S; Segers RP; Kobisch M; Mieli L; Soerensen V; Hüssy D; Miserez R; Zimmermann W; Inderbitzin F; Frey J
    Vet Microbiol; 2004 Apr; 99(3-4):227-38. PubMed ID: 15066725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunosorbent assay based on the recombinant ApxIa, ApxIIa, and ApxIIIa toxins of Actinobacillus pleuropneumoniae and its application to field sera.
    Shin MK; Kang ML; Cha SB; Lee WJ; Sung JH; Yoo HS
    J Vet Diagn Invest; 2011 Jul; 23(4):736-42. PubMed ID: 21908316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of diagnostic assays for the serological detection of Actinobacillus pleuropneumoniae on samples of known or unknown exposure.
    Opriessnig T; Hemann M; Johnson JK; Heinen S; Giménez-Lirola LG; O'Neill KC; Hoang H; Yoon KJ; Gottschalk M; Halbur PG
    J Vet Diagn Invest; 2013 Jan; 25(1):61-71. PubMed ID: 23293160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.
    Shao M; Wang Y; Wang C; Guo Y; Peng Y; Liu J; Li G; Liu H; Liu S
    Acta Vet Scand; 2010 Sep; 52(1):52. PubMed ID: 20831818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and use of a multiplex polymerase chain reaction assay based on Apx toxin genes for genotyping of Actinobacillus pleuropneumoniae isolates.
    Rayamajhi N; Shin SJ; Kang SG; Lee DY; Ahn JM; Yoo HS
    J Vet Diagn Invest; 2005 Jul; 17(4):359-62. PubMed ID: 16130995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 15 in pig sera.
    Teshima K; Lee J; To H; Kamada T; Tazumi A; Hirano H; Maruyama M; Ogawa T; Nagai S; Turni C; Tsutsumi N
    J Vet Med Sci; 2017 Dec; 79(12):1968-1972. PubMed ID: 29070770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.
    MacInnes JI; Gottschalk M; Lone AG; Metcalf DS; Ojha S; Rosendal T; Watson SB; Friendship RM
    Can J Vet Res; 2008 Apr; 72(3):242-8. PubMed ID: 18505187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
    Loera-Muro A; Angulo C
    Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Apx toxins by field strains of Actinobacillus pleuropneumoniae and Actinobacillus suis.
    Kamp EM; Vermeulen TM; Smits MA; Haagsma J
    Infect Immun; 1994 Sep; 62(9):4063-5. PubMed ID: 8063425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of antibodies to five Actinobacillus pleuropneumoniae serovars using bead-based multiplex analysis.
    Berger SS; Lauritsen KT; Boas U; Lind P; Andresen LO
    J Vet Diagn Invest; 2017 Nov; 29(6):797-804. PubMed ID: 28685648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new variant of Actinobacillus pleuropneumoniae serotype 3 lacking the entire apxII operon.
    Kuhnert P; Rohde J; Korczak BM
    J Vet Diagn Invest; 2011 May; 23(3):556-9. PubMed ID: 21908290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the CAMP phenomenon in Actinobacillus pleuropneumoniae with the RTX toxins ApxI, ApxII and ApxIII.
    Frey J; Kuhn R; Nicolet J
    FEMS Microbiol Lett; 1994 Dec; 124(2):245-51. PubMed ID: 7813893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.